Sales & Marketing News | pharmaphorum

News

A woman holds her hands up in a signal of 'No'

Sarepta resists as FDA seeks pause on Elevidys use

Sarepta has defied an FDA request to halt all use of its gene therapy for Duchenne muscular dystrophy, creating an intriguing regulatory impasse.

News

BMS, Pfizer take DTC route for blood thinner Eliquis

BMS, Pfizer launch direct-to-patient sales for anticoagulant Eliquis, as a report cites conflict-of-interest concerns about the emerging DTC channel.

News

GSK's growth plans dented by Blenrep setback

FDA advisors have voted that the benefit/risk profile of GSK's multiple myeloma therapy, Blenrep, does not support its approval in the US.

News

Colleagues discuss information on a laptop screen

EVERSANA unveils new AI-powered pharmacovigilance suite

EVERSANA has launched a new pharmacovigilance platform to answer the need for advanced analytics and AI in drug safety monitoring and risk management.

News

Bayer extends CEO contract amid 'signs of success'

Bayer's chief executive Bill Anderson looks set to keep his role until nearly the decade, as his turnaround plan starts to deliver results.

News

UK plan to lead life sciences gets mixed response

The UK has unveiled its plan to revitalise the life sciences sector and become a global leader by 2030, but a pharma trade group says it falls short.

Sarepta resists as FDA seeks pause on Elevidys use

BMS, Pfizer take DTC route for blood thinner Eliquis

GSK's growth plans dented by Blenrep setback

EVERSANA unveils new AI-powered pharmacovigilance suite

Bayer extends CEO contract amid 'signs of success'

UK plan to lead life sciences gets mixed response

LSX2026: On promise and patience, with Hans Schambye

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks